Mistras Group, Inc. (MG) Cash Flow Statement
Mistras Group, Inc. (MG) generated $54.3M of operating cash flow over the twelve months to 2026-06-30, spent $25.4M on capital expenditure and had free cash flow of $28.9M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
MGMistras Group, Inc.Follow MG — free
—
Price chart with a free account
- Market cap
- 685.7M
- P/E TTM
- 25.9
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 2 Nov, in 9 days
| Line | FY2012 May 12 | FY2013 May 13 | FY2014 May 14 | FY2015 May 15 | FY2016 May 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 31.4 | 43.5 | 36.9 | 49.8 | 68.1 | 55.2 | 41.7 | 59.1 | 67.8 | 42.3 | 26.4 | 26.7 | 50.1 | 33.0 | 54.3 | |
| Capital expenditure | 9.6 | 12.5 | 16.9 | 15.1 | 14.9 | 19.3 | 20.6 | 22.0 | 15.4 | 18.2 | 12.6 | 20.9 | 17.9 | 24.7 | -25.4 | |
| Free cash flow | 21.8 | 31.0 | 20.0 | 34.7 | 53.3 | 35.9 | 21.1 | 37.1 | 52.4 | 24.1 | 13.8 | 5.9 | 32.2 | 8.3 | 28.9 | |
| Share repurchases | — | — | — | — | 0.0 | 15.9 | 0.0 | 0.0 | — | — | — | — | — | — | — | |
| Stock-based compensation | 5.1 | 6.3 | 6.3 | 6.6 | 6.5 | 6.6 | 6.1 | 5.8 | 5.9 | 5.4 | 5.3 | 5.7 | 5.1 | 7.8 | — |
USD millions · SEC XBRL
Mistras Group, Inc. — questions
- What is Mistras Group, Inc.'s operating cash flow?
- $54.3M over the twelve months to 2026-06-30.
- How much does Mistras Group, Inc. spend on capital expenditure?
- $25.4M over the twelve months to 2026-06-30.
- What is Mistras Group, Inc.'s free cash flow?
- $28.9M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Mistras Group, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.